Close
Almac
Achema middle east

News

Regeneron Looks to Infusing More Funds into Gene Editing

Regeneron Pharmaceuticals is going ahead and investing more funds into gene editing, as it has announced a collaboration with Tessera Therapeutics in December 2025, so as to create an experimental program pertaining to rare liver and lung disease. At the...

Trump To Exempt UK-Origin Pharmaceuticals from Tariffs

The Trump administration has lined up yet another country-specific trade agreement, and this time it is going to be with the U.K., which confers the biggest break on pharmaceutical import tariffs yet with Washington. For its part, the U.K., which...

How Poor Medical Care in Nursing Homes Leads to Preventable Health Complications

Older adults in nursing homes rely on consistent, accurate medical care to stay healthy. Simple health issues can turn into serious complications when that care falls below basic standards. Many of these problems develop slowly and become dangerous before...

Addressing Industrial Health Risks: Pharma’s Key Role

Workers in various industries face significant health risks due to exposure to hazardous chemicals, toxic materials, and unsafe working conditions. These risks can lead to severe long-term health problems that affect individual well-being and overall workforce productivity. Pharmaceutical companies play...

Azerbaijan, Jordan Explore Joint Pharmaceutical Venture

Azerbaijan and Jordan are looking out for new opportunities in order to establish a joint pharmaceutical venture, thereby signalling a very robust step towards much deeper economic cooperation. As per Azernews, this occurrence was highlighted by Yarub Al-Guda, the Jordanian...

India, Switzerland Discuss Pharma and Biotech Collaboration

Piyush Goyal, the Commerce and Industry Minister, met Helene Budliger Artieda, the visiting Swiss State Secretary for Economic Affairs, and discussed cooperation when it comes to research and development as well as pharma and biotech collaboration with a view...

Iraq To Open Largest Cancer Drug Factory in The Region

Iraq looks forward to inaugurating the region’s largest cancer drug factory in Abu Ghraib, which is situated 32 kilometers – equivalent to 20 miles west of Baghdad, in December 2025 at a cost of around 50 million euros. This step...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »